Put Options

6 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q2 2024

Aug 14, 2024

SELL
N/A
-12,400 Reduced 77.5%
3,600 $0
Q1 2024

May 15, 2024

BUY
N/A
16,000 New
16,000 $0
Q3 2023

Nov 14, 2023

SELL
N/A
-6,300 Reduced 12.43%
44,400 $0
Q2 2023

Aug 14, 2023

BUY
N/A
46,100 Added 1002.17%
50,700 $0
Q1 2023

May 15, 2023

SELL
N/A
-2,100 Reduced 31.34%
4,600 $0
Q4 2022

Feb 14, 2023

BUY
$0.0 - $9.95 $0 - $66,665
6,700 New
6,700 $0

Others Institutions Holding LNDC

About LANDEC CORP \CA\


  • Ticker LNDC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 29,595,600
  • Description
  • Landec Corporation operates as a diversified health and wellness company. The company manufactures pharmaceutical-grade sodium hyaluronate (HA)-based biomaterials for primary use in the ophthalmic and orthopedic markets. It also provides product development services to its partners for HA-based, as well as non-HA based, aseptically formulated, a...
More about LNDC
Track Ken Griffin's Portfolio

Track Ken Griffin Portfolio

Follow Ken Griffin (Citadel Advisors LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.